BioCardia, Inc. (BCDA) Misses Q2 EPS by 2c

BioCardia, Inc. (NASDAQ: BCDA) reported Q2 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $43 million versus the consensus estimate of $340 thousand.

For earnings history and earnings-related data on BioCardia, Inc. (BCDA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Reading (RDI) Tops Q2 EPS by 4c